Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Resverlogix value decimated by RVX-208 failure

22:50 EDT 27 Jun 2013 | SCRIP

Resverlogix lost nearly all of its value on 27 June when its stock sank 92.6% from $2.99 to $0.22 per share – dropping its market cap from $221.9 million to $16.4 million in one and a half hours of trading – after the Canadian company...

Original Article: Resverlogix value decimated by RVX-208 failure

NEXT ARTICLE

More From BioPortfolio on "Resverlogix value decimated by RVX-208 failure"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story